CD79b is a cell surface antigen whose expression is restricted to B cells, with the exception of plasma cells. It is expressed in a majority of the B-cell−derived malignancies, including NHL and chronic lymphocytic leukemia. The gene discussed is CD53; the disease is B-cell chronic lymphocytic leukemia.